Warby Parker Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Warby Parker Inc. (WRBY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $4.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-08-06
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-06-30 was $4.46M, a 1664.43% increase year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-12-31 was $116.00K, a 88.50% decline year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2025-09-30 was $231.00K, a 7.44% increase year-over-year.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $822.00K, a 70.74% decline from fiscal 2024.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $2.81M, a 42.98% decline from fiscal 2023.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $4.93M, a 36.26% decline from fiscal 2022.
- Warby Parker Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $7.73M, a 95.38% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $4.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.46M 10-Q · filed 2026-08-06 | $4.58M derived: sum of 3 quarters · filed 2026-08-06 | $4.81M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $116.00K derived: sum of 2 quarters · filed 2026-05-07 | $347.00K derived: sum of 3 quarters · filed 2026-05-07 | $600.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2025-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $347.00K derived: sum of 2 quarters · filed 2026-02-26 | $600.00K derived: sum of 3 quarters · filed 2026-02-26 | $822.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $231.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $484.00K derived: sum of 2 quarters · filed 2025-11-06 | $706.00K 10-Q · filed 2025-11-06 | $1.72M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $253.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $475.00K 10-Q · filed 2025-08-08 | $1.48M derived: sum of 3 quarters · filed 2026-02-26 | $1.70M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $222.00K 10-Q · filed 2025-05-08 | $1.23M derived: sum of 2 quarters · filed 2026-02-26 | $1.45M derived: sum of 3 quarters · filed 2026-02-26 | $2.88M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.22M derived: sum of 2 quarters · filed 2026-02-26 | $2.65M derived: sum of 3 quarters · filed 2026-02-26 | $2.81M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.65M derived: sum of 2 quarters · filed 2024-11-07 | $1.80M 10-Q · filed 2024-11-07 | $1.87M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.58M 10-Q · filed 2024-08-08 | $1.66M derived: sum of 3 quarters · filed 2026-02-26 | $2.36M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $155.00K 10-Q · filed 2024-05-09 | $229.00K derived: sum of 2 quarters · filed 2026-02-26 | $934.00K derived: sum of 3 quarters · filed 2026-02-26 | $4.89M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $779.00K derived: sum of 2 quarters · filed 2026-02-26 | $4.74M derived: sum of 3 quarters · filed 2026-02-26 | $4.93M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $705.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $4.66M derived: sum of 2 quarters · filed 2023-11-08 | $4.85M 10-Q · filed 2023-11-08 | $6.05M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $4.15M 10-Q · filed 2023-08-09 | $5.35M derived: sum of 3 quarters · filed 2025-02-27 | $5.73M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $191.00K 10-Q · filed 2023-05-09 | $1.39M derived: sum of 2 quarters · filed 2025-02-27 | $1.77M derived: sum of 3 quarters · filed 2025-02-27 | $2.04M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.58M derived: sum of 2 quarters · filed 2025-02-27 | $1.85M derived: sum of 3 quarters · filed 2025-02-27 | $7.73M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $381.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $651.00K derived: sum of 2 quarters · filed 2022-11-10 | $6.53M 10-Q · filed 2022-11-10 | $72.58M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $6.15M 10-Q · filed 2022-08-11 | $72.20M derived: sum of 3 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $5.88M 10-Q · filed 2022-05-16 | $71.93M derived: sum of 2 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $66.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $167.39M 10-K · filed 2024-02-29 | $167.40M 10-K · filed 2022-03-18 | ||
| 2021-09-30 | $101.33M 10-Q · filed 2021-11-12 | ||||
| 2020-12-31 | $17.84M 10-K · filed 2023-02-28 | $17.80M 10-K · filed 2022-03-18 | |||
| 2019-12-31 | $6.40M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |